^
Association details:
| Biomarker: | TTN mutation + IDH2 mutation |
|---|---|
| Cancer: | Glioma |
| Drug: | temozolomide (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Molecular subtype specific biomarkers improve prediction of temozolomide therapy in low grade glioma
Excerpt:
TTN obviously correlated with PFS (p=0.01) and OS (p < 0.01) in IDHmut-non-codel cohort.
